137 related articles for article (PubMed ID: 1725563)
1. Studies on the importance of the proposed release of nitric oxide from platelets.
Mollace V; Salvemini D; Vane J
Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563
[TBL] [Abstract][Full Text] [Related]
2. Direct electrochemical measurement of nitric oxide released from human platelets.
Malinski T; Radomski MW; Taha Z; Moncada S
Biochem Biophys Res Commun; 1993 Jul; 194(2):960-5. PubMed ID: 8343175
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Salvemini D; de Nucci G; Vane JR
Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
[TBL] [Abstract][Full Text] [Related]
6. Cultured astrocytoma cells generate a nitric oxide-like factor from endogenous L-arginine and glyceryl trinitrate: effect of E. coli lipopolysaccharide.
Salvemini D; Mollace V; Pistelli A; Anggård E; Vane J
Br J Pharmacol; 1992 Aug; 106(4):931-6. PubMed ID: 1327394
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
Mollace V; Salvemini D; Sessa WC; Vane JR
J Pharmacol Exp Ther; 1991 Sep; 258(3):820-3. PubMed ID: 1716310
[TBL] [Abstract][Full Text] [Related]
8. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
9. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.
Salvemini D; Mollace V; Pistelli A; Anggard E; Vane J
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):982-6. PubMed ID: 1310543
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide.
Salvemini D; Pistelli A; Mollace V; Anggård E; Vane J
Biochem Pharmacol; 1992 Jul; 44(1):17-24. PubMed ID: 1378739
[TBL] [Abstract][Full Text] [Related]
12. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process.
Berkels R; Klaus W; Boller M; Rösen R
Thromb Haemost; 1994 Aug; 72(2):309-12. PubMed ID: 7831670
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
14. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
16. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Mollace V; Salvemini D; Anggard E; Vane J
Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
[TBL] [Abstract][Full Text] [Related]
18. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
20. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
